Covance Shanghai strengthens safety pharmacology capabilities for in-house IND packages in Asia

Covance Shanghai is pleased to announce an expansion of its general toxicology capabilities to include safety pharmacology studies, allowing our Asia-Pacific clients to more easily complete their IND requirements for CFDA regulations. What are the new safety pharmacology offerings? The general tox team in Shanghai is now capable of running …